As demand for CAR T therapies strain traditional manufacturing, Autolus Therapeutics has tapped Cellares to evaluate whether that company’s automated Cell Shuttle platform can support expanded ...
The way we build cars is changing faster than most people realize. These changes go beyond electric powertrains or self-driving features to affect the actual manufacturing process on a scale that’ll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results